Fulgent Genetics Inc. Overview
Fulgent Genetics, Inc., a technology company based in Temple City, United States, operates within the Health Care sector, specifically under Health Care Providers & Services. The company is publicly traded on the Nasdaq with its financials reported in USD.
Recent Financial Performance
As of July 30, 2025, Fulgent Genetics Inc. closed at a price of $17.18 per share. Over the past year, the company’s stock has experienced fluctuations, reaching a 52-week high of $25 on August 6, 2024, and a 52-week low of $14.57 on March 3, 2025. The company’s market capitalization stands at approximately $560.47 million.
Financial Ratios
The Price Earnings (P/E) ratio for Fulgent Genetics Inc. is currently at -12.878, indicating that the company is not generating positive earnings per share at this time.
Business Operations
Fulgent Genetics specializes in providing genetic testing services, offering crucial clinical information to physicians. This service is integral to the company’s operations, positioning it as a key player in the health care technology sector.
Conclusion
Fulgent Genetics Inc. continues to focus on its core competency of genetic testing services, aiming to support healthcare providers with essential clinical data. Despite the current negative P/E ratio, the company maintains a significant market presence with a robust market capitalization.